Dr. Mohamed O. Othman, MD
Claim this profileBaylor College of Medicine
Studies Digestive Cancer
Studies Gastrointestinal Cancer
17 reported clinical trials
27 drugs studied
Affiliated Hospitals
Clinical Trials Mohamed O. Othman, MD is currently running
Traction Device
for Digestive System Tumors
The goal of this prospective, randomized, controlled trial conducted at Baylor St. Luke's Medical Center is to compare the effectiveness and clinical outcomes of using a traction device in colonic endoscopic submucosal dissection (ESD) to those of using conventional ESD. The investigators of this study hypothesize that use of the traction device will help expedite colonic endoscopic submucosal dissections.
Recruiting1 award N/A3 criteria
Novel Rigidizing Overtube
for Gastrointestinal Cancer
The goal of this prospective, single centre, 1:1, Post Market, randomized controlled, Investigator Initiated trial, is to compare the feasibility, safety efficacy, and clinical outcomes of colonic endoscopic submucosal dissection (ESD) utilizing a novel rigidizing overtube called Pathfinder® Endoscope Overtube (Neptune Medical, Burlingame California, USA) device in comparison to conventional ESD. The research team hypothesize that with utilizing a novel rigidizing overtube the procedure time including dissection speed and closure time will be faster due to higher scope stability and greater control over the scope tip. Subsequently, the investigators anticipate lower immediate or delayed adverse events.
Recruiting1 award N/A3 criteria
More about Mohamed O. Othman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mohamed O. Othman, MD has experience with
- Endoscopic Submucosal Dissection
- Novel Rigidizing Overtube
- Traction Device
- Transoral Incisionless Fundoplication
- Prilosec
- Nexium
Breakdown of trials Mohamed O. Othman, MD has run
Digestive Cancer
Gastrointestinal Cancer
Gastrointestinal Tumors
Gastrointestinal Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamed O. Othman, MD specialize in?
Mohamed O. Othman, MD focuses on Digestive Cancer and Gastrointestinal Cancer. In particular, much of their work with Digestive Cancer has involved treating patients, or patients who are undergoing treatment.
Is Mohamed O. Othman, MD currently recruiting for clinical trials?
Yes, Mohamed O. Othman, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Mohamed O. Othman, MD has studied deeply?
Yes, Mohamed O. Othman, MD has studied treatments such as Endoscopic Submucosal Dissection, Novel Rigidizing Overtube, Traction Device.
What is the best way to schedule an appointment with Mohamed O. Othman, MD?
Apply for one of the trials that Mohamed O. Othman, MD is conducting.
What is the office address of Mohamed O. Othman, MD?
The office of Mohamed O. Othman, MD is located at: Baylor College of Medicine, Houston, Texas 77030 United States. This is the address for their practice at the Baylor College of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.